Two organisations plan to explore new clinical applications for micro-volume benchtop cell analysis systems, and accelerate clinical research programmes
Guava Technologies and Partners HealthCare have formed a clinical research alliance.
The two organisations plan to explore new clinical applications for Guava's micro-volume benchtop cell analysis systems, as well as to use Guava's innovative tools to accelerate Partners's clinical research programmes.
Guava Technologies's personal cell analysis systems, the Guava PCA and Guava PCA-96, significantly simplify cell analysis and biological research by providing powerful, compact systems that scientists in the lab can use at their benchtop for a variety of testing purposes with less than a day of training.
Requiring only small numbers of cells in microlitre sample volumes, Guava's PCA systems produce highly accurate and easy-to-read results when researchers need them, thus streamlining the R and D process and markedly increasing research productivity.
"The ability to perform high-throughput experiments is key to the progress of our work," said Raju Kucherlapati, scientific director of the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics.
"Being able to perform micro-volume cell analysis assays in a 96-well format on our benchtops is highly beneficial to our research teams, as we can now conduct cell-based testing easily in our own labs.
"This gives us better control of our experiments and allows us to quickly make decisions and move to the next step in our research.
"Our alliance with Guava Technologies will increase both the speed and productivity of some of our key research programmes".
